T. Rowe Price Global Value Equity continues to earn our conviction as a compelling option for investors seeking value-oriented global equities exposure. The substantially experienced and stable investment team led by Sebastian Mallet has continued to execute a differentiated and effective investment process efficiently, upholding our confidence in the strategy to deliver long-term outperformance. The strategy’s opportunistic value approach spans the value spectrum and leverages rigorous bottom-up research and effective execution. These attributes provide a robust foundation for the strategy’s ability to deliver risk-adjusted outperformance over the long term, supporting an Above Average rating for the People and Process pillars.
T. Rowe Price Global Value Equity Fund Class I PRIGX
- NAV / 1-Day Return 24.75 / −0.24 %
- Total Assets 307.4M
-
Adj. Expense Ratio
0.680%
- Expense Ratio 0.680%
- Distribution Fee Level Low
- Share Class Type Institutional
- Category Global Large-Stock Value
- Investment Style Large Value
- Min. Initial Investment 500,000
- Status Open
- TTM Yield 1.93%
- Turnover 77%
USD | NAV as of Aug 07, 2026 | 1-Day Return as of Aug 07, 2026, 6:43 PM GMT+0
Morningstar’s Analysis PRIGX
Will PRIGX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 21.5
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Alphabet Inc Class C | 3.63 | 11M | Communication Services |
Microsoft Corp | 2.94 | 9M | Technology |
Micron Technology Inc | 2.61 | 8M | Technology |
Intel Corp | 2.07 | 6M | Technology |
ExxonMobil Holdings Corp | 2.06 | 6M | Energy |
JPMorgan Chase & Co | 1.98 | 6M | Financial Services |
AbbVie Inc | 1.57 | 5M | Healthcare |
Aramark | 1.57 | 5M | Industrials |
CVS Health Corp | 1.57 | 5M | Healthcare |
Centene Corp | 1.55 | 5M | Healthcare |